BRCA1 and Friedreich ataxia: We next tested whether the QIBC-based PARPi-DDR approach could faithfully recapitulate known clinically relevant mechanisms of PARPi sensitivity, specifically loss of BRCA1/21,2 and Fanconi anemia (FA) genes50,51.